DNA Ginkgo Bioworks Holdings, Inc. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
14:17
Jun 03
Jun 03
Author exits DNA position for portfolio management reasons, not due to a change in thesis, so no forward directional call is made.
20:25
Jun 02
Jun 02
Speaker expresses favorable view on $DNA but considers it premature; no trade commitment.
LOW
19:57
Jun 02
Jun 02
The author warns that the digital biology narrative will cause many biotechs to rerate without fundamental support, advising caution on picking the right names rather than taking a directional position.
19:24
Jun 02
Jun 02
Buy DNA speculatively on the Microsoft partnership and OpenAI collaboration, betting AI-driven biotech theme gains momentum.
MED
08:02
Mar 02
Mar 02
The article explicitly describes a collaboration between Google and Ginkgo Bioworks where GPT-5 connected to an autonomous lab reduced protein production cost by 40% and compressed 150 years of work i
The article explicitly describes a collaboration between Google and Ginkgo Bioworks where GPT-5 connected to an autonomous lab reduced protein production cost by 40% and compressed 150 years of work into weeks. This validates Ginkgo's platform-as-a-service model and signals growing commercial adoption of AI-driven synthetic biology.
Risk: Partnership dependency on Google; Ginkgo's revenue still small and path to profitability uncertain.
20:34
Feb 09
Feb 09
Long $DNA — speaker explicitly states 'I've also begun a starter position in $DNA today' citing Ginkgo Bioworks' Autonomous Laboratory + OpenAI GPT-5 milestone achieving 40% improvement over state-of-the-art benchmark.
HIGH
About DNA Analyst Coverage
Buzzberg tracks DNA (Ginkgo Bioworks Holdings, Inc.) across 4 sources. 2 bullish vs 0 bearish calls from 4 analysts. Sentiment: predominantly bullish (33%). 6 total trade ideas tracked.